In vivo genetic mutations define predominant functions of the human T-cell leukemia/lymphoma virus p12I protein

Blood

Volumn 113, Issue 16, 2009, Pages 3726-3734

  Fukumoto, Risaku ^a   Andresen, Vibeke ^a   Bialuk, Izabela ^a   Cecchinato, Valentina ^a   Walser, Jean Claude ^b   Valeri, Valerio W ^a   Nauroth, Julie M ^a   Gessain, Antoine ^c   Nicot, Christophe ^d   Franchini, Genoveffa ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^c INSTITUT PASTEUR   (France)

^d UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALNEXIN; CALRETICULIN; INTERLEUKIN 2 RECEPTOR; ISOPROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MEMBRANE PROTEIN; TOLL LIKE RECEPTOR; VIRUS PROTEIN; HLA ANTIGEN CLASS 1; IL2RB PROTEIN, HUMAN; IL2RG PROTEIN, HUMAN; INTERLEUKIN 2 RECEPTOR BETA; INTERLEUKIN 2 RECEPTOR GAMMA; LYMPHOCYTE ANTIGEN RECEPTOR; P12I PROTEIN, HUMAN T LYMPHOTROPIC VIRUS 1; P12I PROTEIN, HUMAN T-LYMPHOTROPIC VIRUS 1; SIGNAL PEPTIDE;

AMINO ACID SUBSTITUTION; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CELL MIGRATION; CELL SURFACE; CELL SURVIVAL; CELLULAR DISTRIBUTION; DOWN REGULATION; ENDOPLASMIC RETICULUM; GENE MUTATION; GENETIC ANALYSIS; GOLGI COMPLEX; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; IN VIVO STUDY; MOLECULAR WEIGHT; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN INTERACTION; SYNAPSE; ANIMAL; CAPPING PHENOMENON; CELL PROLIFERATION; CELL STRAIN COS1; CERCOPITHECUS; GENETICS; HELA CELL; HUMAN T CELL LEUKEMIA VIRUS INFECTION; HYDROPHOBICITY; IMMUNOLOGICAL SYNAPSE; LEUKEMIA CELL LINE; METABOLISM; MUTATION; PROTEIN BINDING; PROTEIN TRANSPORT;

ANIMALS; CALNEXIN; CALRETICULIN; CELL PROLIFERATION; CELL SURVIVAL; CERCOPITHECUS AETHIOPS; COS CELLS; GOLGI APPARATUS; HELA CELLS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HTLV-I INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; HYDROPHOBICITY; IMMUNOLOGIC CAPPING; IMMUNOLOGICAL SYNAPSES; INTERLEUKIN RECEPTOR COMMON GAMMA SUBUNIT; INTERLEUKIN-2 RECEPTOR BETA SUBUNIT; JURKAT CELLS; MEMBRANE PROTEINS; MUTATION; PROTEIN BINDING; PROTEIN SORTING SIGNALS; PROTEIN TRANSPORT; RECEPTORS, ANTIGEN, T-CELL; VIRAL REGULATORY AND ACCESSORY PROTEINS;

EID: 65549094676     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2008-04-146928     Document Type: Article

References (32)

1. Nicot C, Harrod RL, Ciminale V, Franchini G. Human T-cell leukemia/lymphoma virus type 1 non-structural genes and their functions. Oncogene. 2005;24:6026-6034. (Pubitemid 43086120)
2. Mesnard JM, Barbeau B, Devaux C. HBZ, a new important player in the mystery of adult T-cell leukemia. Blood. 2006;108:3979-3982. (Pubitemid 44913265)
3. Franchini G. Molecular mechanisms of human T-cell leukemia/lymphotropic virus type I infection. Blood. 1995;86:3619-3639.
4. Ciminale V, Pavlakis GN, Derse D, Cunningham CP, Felber BK. Complex splicing in the human T-cell leukemia virus (HTLV) family of retroviruses: novel mRNAs and proteins produced by HTLV-I. J Virol. 1992;66:1737-1745.
5. Koralnik I, Lemp JF Jr, Gallo RC, Franchini G. In vitro infection of human macrophages by human T-cell leukemia/lymphotropic virus type I (HTLV-I). AIDS Res Hum Retroviruses. 1992;8:1845-1849.
6. Dekaban GA, Peters AA, Mulloy JC, et al. The HTLV-I orf I protein is recognized by serum antibodies from naturally infected humans and experimentally infected rabbits. Virology. 2000;274:86-93.
7. Pique C, Ureta-Vidal A, Gessain A, et al. Evidence for the chronic in vivo production of human T cell leukemia virus type I Rof and Tof proteins from cytotoxic T lymphocytes directed against viral peptides. J Exp Med. 2000;191:567-572.
8. I protein greatly influences its stability. J Virol. 1999;73:6460-6467.
9. Martins ML, Soares BC, Ribas JG, et al. Frequency of p12K and p12R alleles of HTLV type 1 in HAM/TSP patients and in asymptomatic HTLV type 1 carriers. AIDS Res Hum Retroviruses. 2002;18:899-902.
10. Ding W, Albrecht B, Luo R, et al. Endoplasmic reticulum and cis-Golgi localization of human T-lymphotropic virus type 1 p12(I): association with calreticulin and calnexin. J Virol. 2001;75:7672-7682.
11. Johnson JM, Nicot C, Fullen J, et al. Free major histocompatibility complex class I heavy chain is preferentially targeted for degradation by human T-cell leukemia/lymphotropic virus type 1 p12(I) protein. J Virol. 2001;75:6086-6094. (Pubitemid 32553139)
12. II proteins encoded by human T-cell leukemia/lymphotropic virus type I open reading frames I and II are localized in three different cellular compartments. J Virol. 1993;67:2360-2366.
13. I protein cooperates with the E5 oncoprotein of bovine papillomavirus in cell transformation and binds the 16-kilodalton subunit of the vacuolar H+ ATPase. J Virol. 1993;67:7701-7704.
14. Ding W, Kim SJ, Nair AM, et al. Human T-cell lymphotropic virus type 1 p12I enhances interleukin-2 production during T-cell activation. J Virol. 2003;77:11027-11039. (Pubitemid 37204294)
15. c chains and affects their expression on the cell surface. J Virol. 1996;70:3599-3605.
16. Nicot C, Mulloy JC, Ferrari MG, et al. HTLV-1 p12(I) protein enhances STAT5 activation and decreases the interleukin-2 requirement for proliferation of primary human peripheral blood mononuclear cells. Blood. 2001;98:823-829.
17. Banerjee P, Feuer G, Barker E. Human T-cell leukemia virus type 1 (HTLV-1) p12I down-modulates ICAM-1 and -2 and reduces adherence of natural killer cells, thereby protecting HTLV-1-infected primary CD4+ T cells from autologous natural killer cell-mediated cytotoxicity despite the reduction of major histocompatibility complex class I molecules on infected cells. J Virol. 2007;81:9707-9717.
18. Ding W, Albrecht B, Kelley RE, et al. Human T-cell lymphotropic virus type 1 p12(I) expression increases cytoplasmic calcium to enhance the activation of nuclear factor of activated T cells. J Virol. 2002;76:10374-10382.
19. Fukumoto R, Dundr M, Nicot C, et al. Inhibition of T-cell receptor signal transduction and viral expression by the linker for activation of T cells-interacting p12I protein of human T-cell leukemia/lymphoma virus type 1. J Virol. 2007;81:9088-9099.
20. Kim SJ, Nair AM, Fernandez S, Mathes L, Lairmore MD. Enhancement of LFA-1-mediated T cell adhesion by human T lymphotropic virus type 1 p12I1. J Immunol. 2006;176:5463-5470.
21. Nicot C, Astier-Gin T, Edouard E, et al. Establishment of HTLV-I-infected cell lines from French, Guianese and West Indian patients and isolation of a proviral clone producing viral particles. Virus Res. 1993;30:317-334.
22. Kimata JT, Wong FH, Wang JJ, Ratner L, Construction and characterization of infectious human T-cell leukemia virus type 1 molecular clones. Virology. 1994;204:656-664. (Pubitemid 24330871)
23. Bazarbachi A, Huang M, Gessain A, et al. Human T-cell-leukemia virus type I in post-transfusional spastic paraparesis: complete proviral sequence from uncultured blood cells. Int J Cancer. 1995;63:494-499.
24. Chou KS, Okayama A, Tachibana N, Lee TH, Essex M. Nucleotide sequence analysis of a full-length human T-cell leukemia virus type I from adult T-cell leukemia cells: a prematurely terminated PX open reading frame II. Int J Cancer. 1995;60:701-706.
25. Furukawa Y, Usuku K, Izumo S, Osame M. Human T cell lymphotropic virus type I (HTLV-I) p12I is dispensable for HTLV-I transmission and maintenance of infection in vivo. AIDS Res Hum Retroviruses. 2004;20:1092-1099. (Pubitemid 39403069)
26. Iñiguez AM, Otsuki K, Magalhaes GP, Silva EA, Vicente AC. Genetic markers on the HTLV-1 p12I protein sequences from Brazilian HAM/TSP patients and asymptomatic HTLV-1 carrier isolates. AIDS Res Hum Retroviruses. 2005;21:580-582. (Pubitemid 40944321)
27. Iñiguez AM, Gastaldello R, Gallego S, Otsuki K, Vicente AC. HTLV-1 p12I protein sequences from South America: truncated proteins and common genetic signatures. AIDS Res Hum Retroviruses. 2006;22:466-469. (Pubitemid 43787773)
28. Seiki M, Hattori S, Kirayama Y, Yoshida M. Human T-cell leukemia/lymphotropic virus: complete nucleotide sequence of the provirus genome integrated in leukemia cell DNA. Proc Natl Acad Sci U S A. 1983;80:3618-3622.
29. Rice P, Longden I, Bleasby A. EMBOSS: the European Molecular Biology Open Software Suite. Trends Genet. 2000;16:276-277.
30. Puntervoll P, Linding R, Gemünd C, et al. ELM server: a new resource for investigating short functional sites in modular eukaryotic proteins. Nucleic Acids Res. 2003;31:3625-3630. (Pubitemid 37448491)
31. Ashrafi GH, Tsirimonaki E, Marchetti B, et al. Downregulation of MHC class I by bovine papillomavirus E5 oncoproteins. Oncogene. 2002;21:248-259. (Pubitemid 34102133)
32. Mulloy JC, Migone T-S, Ross TM, et al. Human and simian T-cell leukemia viruses type 2 (HTLV-2 and STLV-2pan-p) transform T-cells independently of Jak/STAT activation. J Virol. 1998;72:4408-4412.